Clinique de restauration capillaire dirigée par un chirurgien à Levent, Istanbul, depuis 2007.
Tout explorer →Envoyez 3 à 5 photos. Réponse personnelle sous 24 heures — sans intermédiaire.
Demander maintenant →Choisie selon votre type de calvitie et vos objectifs esthétiques.
FUE vs DHI →FUE, DHI ou Algorithmic FUE™ — le Dr Arslan recommande selon vos photographies et votre stade de Norwood.
Obtenir une évaluation → Essayer le calculateur →Membre de FUE Europe. Clinique agréée par le ministère de la Santé. Levent, Istanbul — 60 à 80 % moins cher qu’au Royaume-Uni ou aux États-Unis.
Voir le forfait →Membre de FUE Europe. Agréé par le ministère de la Santé. 17+ ans. 4 500+ interventions réalisées personnellement. Un patient par jour.
Profil complet →Chaque prélèvement et chaque canal, de sa main. Chaque résultat personnellement assumé.
Lire la philosophie →Aucun frais caché. Hôtel, transferts, opération et suivi dans un seul prix.
Voir les tarifs →Silver · Gold · VIP — hôtel 4/5 étoiles · transferts aéroport · PRP inclus
Voir les tarifs → Calculateur de greffons →Chaque cas personnellement dirigé par le Dr Arslan Musbeh, du début à la fin.
Galerie complète →Tous les cas ne nécessitent pas une greffe. Traitements médicaux, thérapies et options spécialisées.
Vue d’ensemble →Guides, outils et contenus experts — rédigés par le Dr Arslan Musbeh.
Tous les articles →Of all the risks in hair transplant surgery, overharvesting is the one that concerns Dr. Arslan Musbeh most when consulting corrective cases. Not because it is the most common outcome, but because it is the most irreversible. A depleted donor zone cannot be restored. The follicles extracted beyond the safe limit are gone permanently — and with them, the options for future restoration.
Overharvesting occurs when the number of follicular units extracted from the donor zone exceeds what that zone can lose without producing visible thinning. The safe extraction limit varies by individual donor density, but a reliable working figure is:
When extraction exceeds these parameters, the donor zone visually thins. The extent of visible thinning correlates with how significantly the extraction ceiling was exceeded. Mild overharvesting produces thinning visible only at very short hair lengths; severe overharvesting produces patchy, obviously depleted donor zones at any hair length.
For patients researching hair transplant procedures, asking specifically about donor management philosophy avant de booking is essential.

Understanding why overharvesting happens requires understanding the incentive structure that drives it. In high-volume, price-competitive hair transplant clinics, graft count is the primary marketing metric. Patients compare offerings by graft count. Cliniques compete on who can offer the most grafts at the lowest price.
This creates a perverse incentive: the clinic that extracts more grafts has a more attractive headline offer, regardless of whether those grafts were safely obtained or produced an inferior result. The damage — depleted donor zone, reduced future options — appears months or years later, long after the booking decision has been made and the money spent.
Specific practices that produce overharvesting:
The consequences of overharvesting unfold over time and affect patients across three dimensions:
| Consequence | Timing | Reversibility |
|---|---|---|
| Visible donor zone thinning | 12-24 months post-surgery | Not reversible — permanent |
| Loss of future transplant options | Immediate (latent) | Partial — body hair may supplement |
| Inability to correct primary result | If correction needed later | Body hair partial workaround only |
| Psychological impact | On discovery — often delayed | Dependent on correction options |
The most damaging long-term consequence is not the visible donor thinning itself — it is the loss of future options. A patient who exhausted their donor zone at 30, and who develops continued native hair loss through their 40s, has no surgical options remaining. They cannot address the continuing frontal recession. They cannot correct the unnatural result of the original over-graft procedure. They are left with a combination of outcomes that no amount of medical management fully addresses.
Patients cannot directly assess a clinic's extraction practices avant de undergoing surgery, but several proxy indicators help identify high-risk operations:
1. Graft count guarantees without individual assessment: No reputable surgeon promises a specific graft count avant de performing a trichoscopy assessment. The safe extraction ceiling is individual. Guaranteed graft counts are a marketing claim, not a clinical assessment.
2. Single-session counts above 4,500: Legitimate single-session procedures rarely exceed 4,500 grafts when donor management is the priority. Sessions advertised at 5,000–8,000 grafts should be questioned specifically about donor zone impact.
3. No discussion of future sessions in the consultation: A surgeon who does not discuss the patient's donor supply as a lifetime resource — and does not address what is preserved for future procedures — is not planning comprehensively.
4. No trichoscopy assessment: Proper donor zone planning requires trichoscopy density measurement. If the clinic does not perform this, they are estimating — not measuring.
For Dr. Arslan's full profile and approach to donor management, visit Hairmedico about us.

At Hairmedico, the first-session graft count is never determined by what can be maximally extracted. It is determined by three factors: what the patient needs to achieve their clinical goals, what can be safely extracted without visible donor impact, and what should be preserved for a potential second session if hair loss continues.
Dr. Arslan's Algorithmic FUE approach includes a formal donor zone map — produced by trichoscopy scanning of the entire safe donor area — that calculates the lifetime extractable graft count for each patient. The first-session extraction is planned within this lifetime budget, with the second-session supply explicitly protected.
This approach means some patients receive a lower first-session graft count than another clinic might quote. It also means those patients have viable options five or ten years later when their hair loss has progressed — an outcome that patients who went to maximum-graft-count clinics can no longer access.
When patients present with overharvested donor zones, the correction options are limited. Two approaches are available:
Body hair transplant: Beard, chest or limb hair can supplement a depleted scalp donor zone. Body hair follicles are thinner in calibre than scalp follicles and have a shorter anagen phase, producing shorter, finer growth. The visual result is less dense and less natural than scalp donor grafts, but can meaningfully add coverage when scalp supply is exhausted.
Scalp micropigmentation (SMP): A non-surgical option that creates the visual impression of short-cropped hair at the back and sides of the scalp, camouflaging the depleted donor zone when hair is worn short. Not a restoration — a visual workaround.
Neither option fully replaces what was lost. Prevention — by choosing a surgeon with an explicit donor management philosophy — is the only complete solution.
See Hairmedico package pricing for all-inclusive procedures designed around lifetime donor management.
Overharvesting occurs when the number of grafts extracted from the donor zone exceeds the safe limit, causing visible thinning at the back and sides of the scalp. This damage is permanent — extracted follicles cannot be restored.
Signs of overharvesting: visible thinning at the back/sides at normal hair lengths, patchy or moth-eaten appearance, see-through donor zone when hair is short. A trichoscopy scan at a qualified clinic can assess donor zone status.
3,000–4,500 grafts is the safe range for most patients in a single session. Above 4,500, over-harvesting risk increases significantly. Dr. Arslan's Algorithmic FUE approach plans within each patient's lifetime donor budget, never extracting beyond the safe ceiling.
All references are peer-reviewed medical publications or official health authority guidelines. No commercial sources.